company background image
FPH logo

Fisher & Paykel Healthcare NZSE:FPH Stock Report

Last Price

NZ$36.50

Market Cap

NZ$21.4b

7D

-2.3%

1Y

22.8%

Updated

23 Jun, 2025

Data

Company Financials +

Fisher & Paykel Healthcare Corporation Limited

NZSE:FPH Stock Report

Market Cap: NZ$21.4b

Fisher & Paykel Healthcare (FPH) Stock Overview

Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. More details

FPH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 13.57% per year

Earnings grew by 184.5% over the past year

Risk Analysis

FPH passed our risk checks.

FPH Community Fair Values

Create Narrative

See what 24 others think this stock is worth. Follow their fair value or set your own to get alerts.

INBS logo
Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
40.3% undervalued intrinsic discount
59.20%
Revenue growth p.a.
7users have liked this narrative
0users have commented on this narrative
38users have followed this narrative
17 days ago author updated this narrative
FPH logo
Fisher & Paykel Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts

Aging Demographics And Product Upgrades Will Expand Respiratory Care

Key Takeaways Product innovation, expansion in hospital and homecare, and operational efficiency are strengthening revenue growth, margin improvement, and pricing power. Global demographic trends and rising healthcare investment are broadening market opportunities and diversifying recurring revenue streams.
View narrative
NZ$35.08
FV
4.1% overvalued intrinsic discount
11.40%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
4 days ago author updated this narrative
View Fisher & Paykel Healthcare Community

Fisher & Paykel Healthcare Corporation Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Fisher & Paykel Healthcare
Historical stock prices
Current Share PriceNZ$36.50
52 Week HighNZ$39.50
52 Week LowNZ$29.39
Beta0.74
1 Month Change1.08%
3 Month Change10.41%
1 Year Change22.77%
3 Year Change80.69%
5 Year Change8.96%
Change since IPO8,011.11%

Recent News & Updates

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Jun 12
Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Recent updates

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Jun 12
Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Unpleasant Surprises Could Be In Store For Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares

Mar 25
Unpleasant Surprises Could Be In Store For Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares

We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Feb 22
We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Paint A Concerning Picture

Feb 07
Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Paint A Concerning Picture

There May Be Some Bright Spots In Fisher & Paykel Healthcare's (NZSE:FPH) Earnings

Dec 05
There May Be Some Bright Spots In Fisher & Paykel Healthcare's (NZSE:FPH) Earnings
author-image

New Product Launches And Capacity Expansion Fuel Optimism Amid Margin Pressure And Growth Uncertainty

Diversification with new products and increased manufacturing capacity may drive revenue, but risks include overestimating demand and resulting profit margin pressures.

The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence

Oct 28
The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon

Oct 08
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon

Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Aug 21
Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Jul 29
Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

Jul 11
Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

Shareholder Returns

FPHNZ Medical EquipmentNZ Market
7D-2.3%2.6%-0.1%
1Y22.8%1.5%5.7%

Return vs Industry: FPH exceeded the NZ Medical Equipment industry which returned 1.5% over the past year.

Return vs Market: FPH exceeded the NZ Market which returned 5.7% over the past year.

Price Volatility

Is FPH's price volatile compared to industry and market?
FPH volatility
FPH Average Weekly Movement4.6%
Medical Equipment Industry Average Movement10.8%
Market Average Movement4.6%
10% most volatile stocks in NZ Market8.7%
10% least volatile stocks in NZ Market3.2%

Stable Share Price: FPH has not had significant price volatility in the past 3 months compared to the NZ market.

Volatility Over Time: FPH's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19347,412Lewis Gradonwww.fphcare.com

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.

Fisher & Paykel Healthcare Corporation Limited Fundamentals Summary

How do Fisher & Paykel Healthcare's earnings and revenue compare to its market cap?
FPH fundamental statistics
Market capNZ$21.40b
Earnings (TTM)NZ$377.20m
Revenue (TTM)NZ$2.02b
56.7x
P/E Ratio
10.6x
P/S Ratio

Is FPH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FPH income statement (TTM)
RevenueNZ$2.02b
Cost of RevenueNZ$750.10m
Gross ProfitNZ$1.27b
Other ExpensesNZ$893.70m
EarningsNZ$377.20m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Nov 26, 2025

Earnings per share (EPS)0.64
Gross Margin62.88%
Net Profit Margin18.66%
Debt/Equity Ratio3.4%

How did FPH perform over the long term?

See historical performance and comparison

Dividends

1.2%
Current Dividend Yield
66%
Payout Ratio

Does FPH pay a reliable dividends?

See FPH dividend history and benchmarks
When do you need to buy FPH by to receive an upcoming dividend?
Fisher & Paykel Healthcare dividend dates
Ex Dividend DateJun 23 2025
Dividend Pay DateJul 04 2025
Days until Ex dividend0 days
Days until Dividend pay date11 days

Does FPH pay a reliable dividends?

See FPH dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/23 00:23
End of Day Share Price 2025/06/19 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fisher & Paykel Healthcare Corporation Limited is covered by 25 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Saul HadassinBarrenjoey Markets Pty Limited
Lyanne HarrisonBofA Global Research
Mathieu ChevrierCitigroup Inc